Cambridge Cognition Holdings plc share price, company news, analysis and interviews

Cambridge Cognition Holdings plc announces the formation of a Scientific Advisory Board to guide brain health strategies and market trends effectively.

Cambridge Cognition Holdings plc partners with ActiGraph to enhance brain health assessments in clinical trials, aiming to improve treatments for CNS disorders.

Cambridge Cognition Holdings plc has announced the appointment of Stuart Gall and Philip Rodgers as independent non-executive Directors, to support the company’s growth plans in the healthcare and technology sectors.

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that on 15 December 2023, the Company granted options over a total of 1,012,465 ordinary shares of 1 pence each in the capital of the Company pursuant to the Company’s 2022 Long Term Incentive Plan. Of these Options: 1.   Options in respect of 411,449 Ordinary Shares were granted to Persons Discharging Managerial Responsibilities (“PDMRs”) as follows: Name Role Number of Ordinary Shares over which Options Granted Total number of Ordinary Shares over which Options held following Grant Total number of Ordinary Shares held Percentage of